Global Solutions:  Trust, Quality, Innovation.

News

WHO recommends groundbreaking malaria vaccine for children at risk

Who Logo

The World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high P. falciparum malaria transmission. The recommendation is based on results from an ongoing pilot programme in Ghana, Kenya and Malawi that has reached more than 800 000 children since 2019.

“This is a historic moment. The long-awaited malaria vaccine for children is a breakthrough for science, child health and malaria control,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “Using this vaccine on top of existing tools to prevent malaria could save tens of thousands of young lives each year.”

Malaria remains a primary cause of childhood illness and death in sub-Saharan Africa. More than 260 000 African children under the age of five die from malaria annually.

In recent years, WHO and its partners have been reporting a stagnation in progress against the deadly disease.

“For centuries, malaria has stalked sub-Saharan Africa, causing immense personal suffering,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “We have long hoped for an effective malaria vaccine and now for the first time ever, we have such a vaccine recommended for widespread use. Today’s recommendation offers a glimmer of hope for the continent which shoulders the heaviest burden of the disease and we expect many more African children to be protected from malaria and grow into healthy adults.”

WHO recommendation for the RTS,S malaria vaccine

Based on the advice of two WHO global advisory bodies, one for immunization and the other for malaria, the Organization recommends that:

WHO recommends that in the context of comprehensive malaria control the RTS,S/AS01 malaria vaccine be used for the prevention of P. falciparum malaria in children living in regions with moderate to high transmission as defined by WHO. RTS,S/AS01 malaria vaccine should be provided in a schedule of 4 doses in children from 5 months of age for the reduction of malaria disease and burden.

Source World Health Organization click here to read more.

Other News

Another high value pharma shipment successfully handled by the Cavalier Logistics UK team

Cold Chain Logistics at minus 80°C

The move required careful planning and temperature control at minus 80°C, with the team managing challenging conditions during collection in ...

Cavalier Logistics will be attending LogiPharma Europe

Cavalier Logistics will be attending LogiPharma Europe in Vienna next week! CEO Robbie Neilson will be there together with several ...

Trusted turn-key cold chain solutions

Cavalier Logistics delivers trusted, turn-key cold chain solutions built for precision and reliability in biopharma logistics. Key validated capabilities include: ...
Cavalier Logistics Durham BioPharma Healthcare Services Centre

Cavalier Logistics Durham BioPharma Healthcare Services Centre

Cavalier Logistics Durham BioPharma Healthcare Services Centre in Research Triangle Park, North Carolina, serves as a key national hub for ...
Scroll to Top